Konstantinos Xynos, Chief Medical Officer at Replimune Group, Inc. (REPL), sold 6,367 shares at $6.47 ($41K) on 2024-05-16, disclosed to the SEC on 2024-05-20.
Open-market sale of $41k REPL by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REPL | SELL | 2025-11-19 | $132K | — | Filing → |
| REPL | SELL | 2025-05-22 | $128K | — | Filing → |
| REPL | SELL | 2024-11-20 | $156K | — | Filing → |